Utilization of Services in a Randomized Trial Testing Phone- and Web-based Behavioral Interventions for Smoking Cessation

Similar documents
Smoking Cessation in People with Severe Mental Illness. Lisa Dixon, M.D., MPH and Melanie Bennett, Ph.D. University of Maryland School of Medicine

Healthcare provider cessation practices in Ontario. Alexey Babayan Knowledge Exchange Forum June 18, 2014

Smoking Cessation: Treatment Options for Nicotine Addiction

OVERVIEW OF BRIEF INTERVENTION FOR RISKY SUBSTANCE USE IN PRIMARY CARE. Prepared by CASAColumbia

D. Main Section of the proposal

Grant ID Page 4 Medical University of South Carolina Implementation of TelASK Quit Connection IVR System in Charleston Area Hospitals

The Economic Impact and Cost-Effectiveness of Glucose Monitoring

UW Medicine Integrated Mental Health Care. Laura Collins MSW, Darcy Jaffe ARNP Jürgen Unützer, MD, MPH, MA

CARE MANAGEMENT FOR LATE LIFE DEPRESSION IN URBAN CHINESE PRIMARY CARE CLINICS

A Partnership to Establish Tobacco free Mental Health and Substance Abuse Treatment Centers

Chart Audits: The how s and why s By: Victoria Kaprielian, MD Barbara Gregory, MPH Dev Sangvai, MD

Self-help interventions for smoking cessation (Review)

MASSACHUSETTS TOBACCO TREATMENT SPECIALIST TRAINING

Sample Size Planning, Calculation, and Justification

Smoking Cessation and Mental Health: A briefing for front-line staff

An Example of SAS Application in Public Health Research --- Predicting Smoking Behavior in Changqiao District, Shanghai, China

Diabetes Prevention in Latinos

Treatment of Prescription Opioid Dependence

How to use the Brief Tobacco Cessation Intervention Form

Smoking cessation in Leumit Health Fund

Smoking Cessation Leadership Center at UCSF and Pfizer Medical Education Group. Request for Proposals (RFP) July 2, 2012

Delivery of Tobacco Dependence Treatment for Tobacco Users with Mental Illness and Substance Use Disorders (MISUD)

Healthy Lifestyle, Tobacco Free and Recovery Lesson for Group or Individual Sessions

University of Ulsan College of Medicine, Asan Medical Center on behalf of the REAL-LATE and the ZEST-LATE trial

Main Section of the Proposal

Funded by North American Menopause Society & Pfizer Independent Grant for Learning & Change # , KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

Low diabetes numeracy predicts worse glycemic control

Pragmatic Seamless Design for Efficacy Trial of Asthma Management with reduced Cost. Mei Lu, PhD Christine Joseph, Ph.D

Smoking Cessation Services in Addiction Treatment: Challenges for Organizations and the Counseling Workforce

Self-management for people with chronic health conditions Innovation Community

Literature Review January 2010

Tobacco Treatment Specialist Certification (CTTS) Program Workshop Manual

Helping People to Stop Smoking

Physician self-efficacy efficacy and primary care management of maternal depression. Copyright 2007, Jenn A. Leiferman,

1. To create a comprehensive Benchmark plan that will assure maximum tobacco cessation coverage to all populations in Rhode Island:

Using web-based videoconferencing to deliver both standard and intensified levels of substance abuse counseling treatment. Van L.

OCTOBER 5-9, 2015 FEB 22-26, 2016 APRIL 25-29, 2016

An Electronic Health Record Alert for Hepatitis C Screening of Baby Boomers in Primary Care: A Cluster Randomized Controlled Trial

Understanding the Pain Trajectory During Treadmill Testing in Peripheral Artery Disease

National Quitline Data Warehouse. Quitline Services Questionnaire

Spine Vol. 30 No. 16; August 15, 2005, pp

TOBACCO CESSATION WORKS: AN OVERVIEW OF BEST PRACTICES AND STATE EXPERIENCES

The Relationship Between Anhedonia & Low Mood

"Starting today, every doctor, nurse, health plan, purchaser, and medical school in America should make treating tobacco dependence a top priority.

Disclosure. I have the following relationships with commercial interests:

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

Oncology Nursing Society Annual Progress Report: 2008 Formula Grant

NEXT STEPS: TREATING TOBACCO AND CREATING HEALTHY MENTAL HEALTH/SUBSTANCE ABUSE TREATMENT FACILITY ENVIRONMENTS PART I

Background on Quitline Referral Programs Request for Clarification on Four Measures

From the Ground Up: The implementation of a Transition Care Program (TOC) and its impact in COPD 30-day readmissions

Transcription:

Utilization of Services in a Randomized Trial Testing Phone- and Web-based Behavioral Interventions for Smoking Cessation Susan M. Zbikowski, Ph.D. Society of Behavioral Medicine April 22-25, 2009

Introduction Telephone counseling 1-2 and web-based 3-6 programs have been demonstrated to be effective Adherence to treatment programs is variable 2 Low utilization of web-based programs is common Utilization has been demonstrated to be associated with outcomes 1 Stead 2006; 2 Fiore 2008; 3 Cobb et al. 2005; 4 Graham et al., 2007; 5 Saul 2007; 6 Zbikowski 2008.

Purpose of Present Study 1 st study to examine utilization of 3 behavioral treatments for cessation (Web, Phone, Phone-Web) in a randomized trial. 1. Demonstrate the association between utilization and cessation outcomes 2. Summarize utilization of behavioral treatments 3. Examine correlates of utilization 4. Discuss implications for improving utilization in future studies

Phone Intervention

Phone-Web Intervention

Measures Baseline Survey Demographics Tobacco use measures Lives with a smoker Social support Quit attempts in past Use of cessation medications and other aids in the past Motivation and confidence Depressive symptoms Perceived benefit of pharmacotherapy, telephone support, web-based support, and group counseling Follow-up Survey (6 months after target quit date) 7-day point prevalence abstinence Chantix use (average # days)

Measures Treatment Utilization Number of calls- total #; proactive plus adhoc Phone duration- total minutes across all calls Number of web logins Web duration- total minutes for all logins Chantix use- average number of days used Computed mean, std dev, range for each utilization variable Calls were classified: 0, 1, 2, 3, 4, or 5+ calls Logins were classified: 0, 1, 2, 3-4, or 5+ logins

Utilization Predicts Abstinence at 6 Months (Odds Ratios and 95% CI) Models Web X 2 =67(13), p <.0001 # Calls.68 (.42-1.10) Call duration 1.03 (1.00-1.07) Web logins 1.16 (1.05-1.29) Web duration 1.0 (.99-1.00) Days of Chantix 1.02 (1.01-1.03) Phone X 2 =67(13), p <.0001 1.87 (1.47-2.28).99 (.98-1.01) Phone-Web X 2 =62(17), p <.0001 1.43 (1.13-1.82) 1.0 (.99-1.01) --- 1.05 (.95-1.15) ---.99 (.99-1.00) 1.02 (1.01-1.03) 1.02 (1.01-1.03)

Utilization of Behavioral Services and Chantix 80 70 60 72.5 67.6 53.9 67.7 60.0 61.5 50 40 30 20 10 0 4.2 4.1 1.6 14.4 3.7 2.4 28.5 Web Phone Phone- Web # calls Call duration (min) # logins Web duration (min) Chantix (days)

Predictors of Utilization by Treatment Web # of Calls Comfort with Internet Tried bupropion in past Phone Duration # Logins Cessation Info from Internet Tried bupropion in past Phone can improve success Web Duration HSI Use of other aids in past

Predictors of Utilization by Treatment Phone # of Calls Marital status Use of NRT in past Phone Duration

Predictors of Utilization by Treatment Phone-Web # of Calls Tried bupropion in past Phone Duration Self-efficacy (-) Comfort with Internet (-) Internet use/wk Tried bupropion in past Lives with smoker (-) # Logins Self-efficacy (-) Previous quit > 6 mo (-) Tried bupropion in past Use of other aids in past Web can improve success Web Duration Self-efficacy (-) Use of other aids in past Web can improve success Social support

Conclusions Greater Chantix Use in was associated with increased quitting success at 6 months Utilization of Behavioral Treatments predicted quitting success Several baseline variables predicted utilization

Implications Programs need to be tailored with consideration for participant characteristics and treatment experience and expectancies. Older age (phone use) Past experience with quitting (type of treatments and length of success) Treatment expectancies (logins and duration) Low self-efficacy (phone/web duration and logins among Phone-Web)

Acknowledgements Gary Swan, PhD; Lisa Jack, MA; Hal Javitz, PhD Jennifer McClure, PhD; Sheryl Catz, PhD; Julie Richards, MPH Mona Deprey, MS; Tim McAfee, MD National Cancer Institute CA071358 Additional support provided by Pfizer

Extra slides if needed - Calls, logins by group -Calls and logins within Phone-Web -Predictors slide with all findings

Calls by Behavioral Treatment 70 60 50 40 30 20 10 0 66 51 48 19 18 20 15 15 9 8 6 8 8 1 2 3 2 1 Web Phone Phone-Web X 2 (10)= 596.8, P<.0001 0 Calls 1 Call 2 Calls 3 Calls 4 Calls 5+ Calls

Web Logins by Behavioral Treatment 45 40 41 37 35 30 25 20 15 10 16 16 24 21 14 14 14 0 logins 1 login 2 logins 3-4 logins 5+ logins 5 3 0 Web Phone-Web X 2 (4)= 67.1, P<.0001

Calls and Web Logins: Phone-Web 5+ calls 7 8 10 10 14 4 calls 3 calls 2 calls 0 1 1 2 2 2 2 3 4 4 5 7 8 5+ logins 3-4 logins 2 logins 1 login 0 logins 1 call 0 0 2 5 0 5 10 15 X 2 (20)= 58.3, P<.0001

Predictors of Utilization by Treatment Web # of Calls Comfort with Internet Tried bupropion in past Phone Duration # Logins Cessation Info from Internet Tried bupropion in past Phone can improve success Web Duration HSI Use of other aids in past Phone # of Calls Marital status Use of NRT in past Phone Duration Phone-Web # of Calls Tried bupropion in past Phone Duration Self-efficacy (-) Comfort with Internet (-) Internet use/wk Tried bupropion in past Lives with smoker (-) # Logins Self-efficacy (-) Previous quit > 6 mo (-) Tried bupropion in past Use of other aids in past Web can improve success Web Duration Self-efficacy (-) Use of other aids in past Web can improve success Social support